Skip to Content

Improved quantification of neutrophil activity in serum is achieved by measuring calprotectin metabolites

A novel serum calprotectin assay (CPa9-HNE) has been developed, which quantifies neutrophil activity and correlates with disease activity in patients with Crohn’s disease and ulcerative colitis.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top